Endocrinology, Vol 136, 262-268, Copyright © 1995 by Endocrine Society

ARTICLES

Expression of a Trk high affinity nerve growth factor receptor in the human prostate

BR Pflug, C Dionne, DR Kaplan, J Lynch and D Djakiew
Department of Cell Biology, Georgetown University Medical Center, Washington, D.C. 20007.

Nerve growth factor-beta (NGF beta) and a NGF beta-immunoreactive protein derived from human prostatic stromal cell secretory protein (hPS) have been shown to stimulate the growth of prostate epithelial cells. An NGF beta-immunoreactive protein has been localized to the stroma of human prostate tissues, and a low affinity NGF receptor (gp75NGFR) has been localized to the adjacent epithelia, consistent with the paracrine regulation of prostate growth. Interestingly, gp75NGFR is progressively lost during neoplastic progression of the human prostate. In this report we have characterized the expression of the signal-transducing component of the NGF receptor, the Trk tyrosine receptor kinase, in prostate epithelial cells that bind exogenous NGF beta and an endogenous NGF beta-immunoreactive protein in hPS. In this context, a pan-Trk antibody that recognizes all of the members of the Trk receptor family (TrkA, TrkB, and TrkC) specifically localized expression of the Trk receptor to the epithelial component of normal prostate tissue, benign prostatic hyperplasia, and adenocarcinoma tissue. The binding of [125I]NGF beta to the surface of primary cultures of human prostate epithelia and the TSU-pr1 human metastatic prostate tumor cell line was displaced with either excess cold NGF beta or hPS, whereas binding was not displaced by epidermal growth factor or platelet-derived growth factor. Scatchard plot analysis of [125I]NGF beta binding to these cells identified a low affinity binding site (Kd = 1.9 x 10(-9) M) and a high affinity binding site (Kd = 1.8 x 10(-11) M) on the primary prostate epithelia, whereas only a high affinity binding site (Kd = 1.3 x 10(-11) M) was observed on the TSU-pr1 tumor cells. Stimulation of TSU-pr1 cells with either NGF beta or hPS induced tyrosine phosphorylation of Trk proteins, whereas no phosphorylation was evident in untreated cells, cells treated with hPS immunoprecipitated with anti-NGF beta antibody, or brain-derived neurotrophic factor- and neurotrophin-3-treated cells. The Trk protein was also observed in these cells by immunoblot analysis with pan-Trk antibody. These results demonstrate a functional Trk receptor in the epithelia of the human prostate that is responsive to exogenous NGF beta and an endogenous NGF beta-immunoreactive protein in hPS, thereby supporting the concept of the paracrine regulation of growth in the human prostate via a stromal neurotrophin-epithelial Trk receptor interaction.

This article has been cited by other articles:

				M. B. Schneider, J. Standop, A. Ulrich, U. Wittel, H. Friess, A. Andren-Sandberg, and P. M. Pour Expression of Nerve Growth Factors in Pancreatic Neural Tissue and Pancreatic Cancer J. Histochem. Cytochem., October 1, 2001; 49(10): 1205 - 1210. [Abstract] [Full Text] [PDF]

				A. Ricci, S. Greco, S. Mariotta, L. Felici, E. Bronzetti, A. Cavazzana, G. Cardillo, F. Amenta, A. Bisetti, and G. Barbolini Neurotrophins and Neurotrophin Receptors in Human Lung Cancer Am. J. Respir. Cell Mol. Biol., October 1, 2001; 25(4): 439 - 446. [Abstract] [Full Text] [PDF]

				L. Calzà, L. Giardino, A. Giuliani, L. Aloe, and R. Levi-Montalcini Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors PNAS, March 16, 2001; (2001) 51626998. [Abstract] [Full Text]

				Z.-w. Zhu, H. Friess, L. Wang, T. Bogardus, M. Korc, J. Kleeff, and M. W. Büchler Nerve Growth Factor Exerts Differential Effects on the Growth of Human Pancreatic Cancer Cells Clin. Cancer Res., January 1, 2001; 7(1): 105 - 112. [Abstract] [Full Text]

				A. Chott, Z. Sun, D. Morganstern, J. Pan, T. Li, M. Susani, I. Mosberger, M. P. Upton, G. J. Bubley, and S. P. Balk Tyrosine Kinases Expressed in Vivo by Human Prostate Cancer Bone Marrow Metastases and Loss of the Type 1 Insulin-Like Growth Factor Receptor Am. J. Pathol., October 1, 1999; 155(4): 1271 - 1279. [Abstract] [Full Text] [PDF]

				M.A. Russo, M.L. Giustizieri, A. Favale, M.C. Fantini, L. Campagnolo, D. Konda, F. Germano, D. Farini, C. Manna, and G. Siracusa Spatiotemporal Patterns of Expression of Neurotrophins and Neurotrophin Receptors in Mice Suggest Functional Roles in Testicular and Epididymal Morphogenesis Biol Reprod, October 1, 1999; 61(4): 1123 - 1132. [Abstract] [Full Text]

				D. J. George, C. A. Dionne, J. Jani, T. Angeles, C. Murakata, J. Lamb, and J. T. Isaacs Sustained in Vivo Regression of Dunning H Rat Prostate Cancers Treated with Combinations of Androgen Ablation and Trk Tyrosine Kinase Inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555) Cancer Res., May 1, 1999; 59(10): 2395 - 2401. [Abstract] [Full Text] [PDF]

				S. Sigala, I. Faraoni, D. Botticini, M. Paez-Pereda, C. Missale, E. Bonmassar, and P. Spano Suppression of Telomerase, Reexpression of KAI1, and Abrogation of Tumorigenicity by Nerve Growth Factor in Prostate Cancer Cell Lines Clin. Cancer Res., May 1, 1999; 5(5): 1211 - 1218. [Abstract] [Full Text] [PDF]

				S. Descamps, X. Lebourhis, M. Delehedde, B. Boilly, and H. Hondermarck Nerve Growth Factor Is Mitogenic for Cancerous but Not Normal Human Breast Epithelial Cells J. Biol. Chem., July 3, 1998; 273(27): 16659 - 16662. [Abstract] [Full Text] [PDF]

				E. Dicou, B. Pflug, M. Magazin, T. Lehy, D. Djakiew, P. Ferrara, V. Nerriere, and D. Harvie Two Peptides Derived from the Nerve Growth Factor Precursor Are Biologically Active J. Cell Biol., January 27, 1997; 136(2): 389 - 398. [Abstract] [Full Text] [PDF]

				L. Calza, L. Giardino, A. Giuliani, L. Aloe, and R. Levi-Montalcini Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors PNAS, March 27, 2001; 98(7): 4160 - 4165. [Abstract] [Full Text] [PDF]